<code id='58AFEBD840'></code><style id='58AFEBD840'></style>
    • <acronym id='58AFEBD840'></acronym>
      <center id='58AFEBD840'><center id='58AFEBD840'><tfoot id='58AFEBD840'></tfoot></center><abbr id='58AFEBD840'><dir id='58AFEBD840'><tfoot id='58AFEBD840'></tfoot><noframes id='58AFEBD840'>

    • <optgroup id='58AFEBD840'><strike id='58AFEBD840'><sup id='58AFEBD840'></sup></strike><code id='58AFEBD840'></code></optgroup>
        1. <b id='58AFEBD840'><label id='58AFEBD840'><select id='58AFEBD840'><dt id='58AFEBD840'><span id='58AFEBD840'></span></dt></select></label></b><u id='58AFEBD840'></u>
          <i id='58AFEBD840'><strike id='58AFEBD840'><tt id='58AFEBD840'><pre id='58AFEBD840'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:97539
          Two $1 bills stapled together to make the shape of a heart against a red background. -- health policy coverage from STAT
          Adobe

          WASHINGTON — Doctors lowered the incidence of heart disease and strokes among their patients when Medicare rewarded them for focusing on sicker patients, according to research of a pilot program released Tuesday in the Journal of the American Medical Association. The pilot program didn’t increase overall costs at all.

          The five-year pilot program is one of many that Medicare has run since the Affordable Care Act created an office to test whether Medicare payment policies can influence doctors in ways that keep patients healthier. That Obama-era initiative has not worked out as well as was hoped, but the Million Hearts Cardiovascular Disease Risk Reduction Model is one of the initiative’s bright spots.

          advertisement

          Medicare paid doctors in the pilot program to assess the risk of heart problems, then Medicare paid them to focus on sicker patients. The pilot paid doctors more when they improved such measurements as blood pressure and cholesterol levels for sicker patients.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          How the Dana
          How the Dana

          ThecorporateofficesofMassachusettsGeneralBrighamhospitalsinAssemblySquareinSomerville.LaneTurner/Glo

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          FDA seeks to regulate lab

          AdobeTheFoodandDrugAdministrationonFridayannounceditsintentiontostartregulatingtestsdevelopedinlabor